v3.26.3
Related Party Transactions
9 Months Ended
Sep. 30, 2026
Related Party Transactions [Abstract]  
Related Party Transactions Related Party TransactionsOn September 20, 2026, the Company and the Memorial Sloan Kettering Cancer Center ("MSKCC") entered into a Sponsored Research Agreement (the "MSKCC Research Agreement") to conduct research with David A. Scheinberg, MD, PhD as the principal investigator who is also a member of the Company's Board of Directors. The Company has agreed to make payments with a total amount of approximately $0.1 million pursuant to the MSKCC Research Agreement.